Sutro Biopharma
Sutro Biopharma is seeking a Senior Bioanalytical Scientist to lead the design and execution of bioanalytical strategies for discovery, preclinical, and early clinical development programs. The role involves developing and qualifying bioanalytical methods for small molecules and antibody-drug conjugates, transferring methods to CROs, and managing external study relationships. This position requires deep expertise in LC-MS/MS-based bioanalysis and the ability to independently drive complex programs in a collaborative environment.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2003
Sutro Biopharma is a clinical-stage biotechnology company based in South San Francisco that discovers, develops, and manufactures protein therapeutics for cancer and autoimmune diseases. It leverages an integrated cell-free protein synthesis platform, XpressCF, to design and produce modalities including cytokine-based immuno-oncology agents, bispecific antibodies, and antibody–drug conjugates (ADCs). Its lead ADC candidates, STRO-001 (anti‑CD74 for multiple myeloma and non‑Hodgkin lymphoma) and STRO-002 (anti‑folate receptor‑α for ovarian and endometrial cancers), are engineered with site-specific linker–warhead placement to optimize therapeutic index. Sutro focuses on directing potent modalities at clinically validated targets to accelerate translation from discovery through manufacturing.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sutro Biopharma.